258 related articles for article (PubMed ID: 2744799)
1. Pentoxifylline--a new drug for the treatment of intermittent claudication.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
J Med; 1988; 19(2):89-107. PubMed ID: 3049876
[TBL] [Abstract][Full Text] [Related]
3. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.
Porter JM; Cutler BS; Lee BY; Reich T; Reichle FA; Scogin JT; Strandness DE
Am Heart J; 1982 Jul; 104(1):66-72. PubMed ID: 7046409
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
Reilly DT; Quinton DN; Barrie WW
N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
[TBL] [Abstract][Full Text] [Related]
5. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
Dettori AG; Pini M; Moratti A; Paolicelli M; Basevi P; Quintavalla R; Manotti C; Di Lecce C
Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of iloprost in patients with intermittent claudication.
Creager MA; Pande RL; Hiatt WR
Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
[TBL] [Abstract][Full Text] [Related]
7. [The influence of chronic pentroxifylline medication on ergometric and hemodynamic parameters in intermittent claudication (author's transl)].
Rudofsky G; Brock FE; Ulrich M; Nobbe F
Med Klin; 1979 Jul; 74(28-29):1093-6. PubMed ID: 556192
[TBL] [Abstract][Full Text] [Related]
8. On the assessment of the efficacy of pentoxifylline (Trental).
Rössner M; Müller R
J Med; 1987; 18(1):1-15. PubMed ID: 3298515
[TBL] [Abstract][Full Text] [Related]
9. Trental 400 in the treatment of intermittent claudication: results of long-term, placebo-controlled administration.
Roekaerts F; Deleers L
Angiology; 1984 Jul; 35(7):396-406. PubMed ID: 6380348
[TBL] [Abstract][Full Text] [Related]
10. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
Hood SC; Moher D; Barber GG
CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication.
Crowder JE; Cohn JB; Savitsky JP; Morgan DL; Slywka J; Cobert BL; Hryniewicki SW; Piccirillo RT; Wilcox CS
Angiology; 1989 Sep; 40(9):795-802. PubMed ID: 2669564
[TBL] [Abstract][Full Text] [Related]
12. [Drug therapy of arterial diseases. A study with Trental 400].
Tannenberg G
Fortschr Med; 1980 Dec; 98(45):1795-8. PubMed ID: 7461576
[TBL] [Abstract][Full Text] [Related]
13. [Training by walking and drug therapy of peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
Vasa Suppl; 1987; 20():384-7. PubMed ID: 3321495
[No Abstract] [Full Text] [Related]
14. Effects of pentoxifylline administration on blood viscosity and leukocyte cytoskeletal function in patients with intermittent claudication.
Rao KM; Simel DL; Cohen HJ; Crawford J; Currie MS
J Lab Clin Med; 1990 Jun; 115(6):738-44. PubMed ID: 2366034
[TBL] [Abstract][Full Text] [Related]
15. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ
Angiology; 1989 Jul; 40(7):639-49. PubMed ID: 2662830
[TBL] [Abstract][Full Text] [Related]
16. Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication.
Aviado DM
Ric Clin Lab; 1983; 13 Suppl 3():263-8. PubMed ID: 6143383
[TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline therapy for chronic claudication: are patients dependent on therapy?
Johnson WC; Watkins MT; Hamilton J; Baldwin D; Walker N
Surgery; 1994 Jun; 115(6):735-9. PubMed ID: 8197567
[TBL] [Abstract][Full Text] [Related]
18. [The effect of oral trapidil therapy on clinical and hemorheological parameters in arteriosclerosis obliterans in comparison to pentoxifylline--a pilot study].
Regenthal R; Voigt H; Reuter W; Preiss R
Z Gesamte Inn Med; 1991 Apr; 46(6):185-90. PubMed ID: 2063598
[TBL] [Abstract][Full Text] [Related]
19. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
Angiology; 2002; 53 Suppl 1():S7-12. PubMed ID: 11865838
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
Angelkort B; Doppelfeld E
Med Klin; 1978 May; 73(21):791-7. PubMed ID: 651768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
